Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
出版年份 2020 全文链接
标题
Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
作者
关键词
-
出版物
Alzheimers Research & Therapy
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-28
DOI
10.1186/s13195-020-00682-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- ATN classification and clinical progression in subjective cognitive decline
- (2020) Jarith L. Ebenau et al. NEUROLOGY
- Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
- (2019) Patrick Oeckl et al. JOURNAL OF ALZHEIMERS DISEASE
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer’s Disease
- (2019) Yachen Shi et al. ACS Chemical Neuroscience
- Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer’s Disease
- (2019) Wei-Wei Li et al. JOURNAL OF ALZHEIMERS DISEASE
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Plasma and CSF neurofilament light
- (2019) Michelle M. Mielke et al. NEUROLOGY
- Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults
- (2019) Hao Hu et al. Aging-US
- Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
- (2019) Arno de Wilde et al. Alzheimers Research & Therapy
- Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer’s Disease
- (2019) Pratishtha Chatterjee et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
- (2019) Samir Abu-Rumeileh et al. Alzheimers Research & Therapy
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Amyloid blood biomarker detects Alzheimer's disease
- (2018) Andreas Nabers et al. EMBO Molecular Medicine
- Amsterdam Dementia Cohort: Performing Research to Optimize Care
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort
- (2018) Arno de Wilde et al. JAMA Neurology
- Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes
- (2018) Inge M.W. Verberk et al. ANNALS OF NEUROLOGY
- Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results
- (2018) Rosalinde E. R. Slot et al. Alzheimers Research & Therapy
- Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease
- (2018) Hedieh Shahpasand-Kroner et al. Alzheimers Research & Therapy
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role
- (2017) C. J. Garwood et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Plasma neurofilament light chain levels in Alzheimer’s disease
- (2017) Wenjun Zhou et al. NEUROSCIENCE LETTERS
- Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
- (2017) Marissa D. Zwan et al. Alzheimers Research & Therapy
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Glial Fibrillary Acidic Protein and Protein S-100B: Different Concentration Pattern of Glial Proteins in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Creutzfeldt-Jakob Disease
- (2017) Sarah Jesse et al. JOURNAL OF ALZHEIMERS DISEASE
- Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease
- (2016) David C. Hondius et al. Alzheimers & Dementia
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects
- (2015) Jon B. Toledo et al. BRAIN
- Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
- (2015) Aiko Ishiki et al. JOURNAL OF NEUROCHEMISTRY
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
- (2014) Frank Jessen et al. Alzheimers & Dementia
- Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions
- (2014) R. Ossenkoppele et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2011) Hugo Vanderstichele et al. Alzheimers & Dementia
- Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain
- (2008) J.E. Simpson et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now